Inhibrx Biosciences Balance Sheet (2023-2025) | INBX

Balance Sheet Dec2023 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Assets
Current Assets
Cash & Equivalents 277.92M226.90M196.33M152.60M216.52M186.60M153.10M
Receivables - Net 0.78M0.27M0.67M0.36M0.21M0.24M0.11M
Receivables - Other 0.61M0.95M0.04M0.73M0.73M
Receivables 1.39M1.22M0.67M0.40M0.21M0.97M0.84M
Prepaid Assets 16.66M13.81M9.99M7.38M6.65M6.43M7.50M
Current Assets 295.36M242.06M207.45M160.40M223.39M193.96M161.42M
Non-Current Assets
Property, Plant & Equipment (Net) 6.42M7.61M6.88M6.20M5.55M4.88M4.31M
Other Non-Current Assets 3.16M6.75M6.71M6.83M6.80M6.81M5.74M
Non-Current Assets 12.54M16.36M15.12M20.37M19.25M18.15M16.05M
Assets 307.89M258.42M222.56M180.77M242.64M212.12M177.47M
Liabilities
Current Liabilities
Accounts Payables 10.95M13.02M12.37M9.24M8.89M8.29M6.77M
Payables 10.95M13.02M12.37M9.24M8.89M8.29M6.77M
Accumulated Expenses 43.30M23.86M29.89M29.89M32.77M28.48M26.96M
Current Leases 2.06M2.17M1.83M1.59M1.97M2.17M2.25M
Total Current Liabilities 56.31M39.05M44.09M40.73M43.64M38.94M35.98M
Non-Current Liabilities
Non-Current Debt 206.97M98.65M99.28M99.92M
Operating Leases 3.17M2.17M1.83M8.05M7.88M7.51M6.99M
Total Liabilities 264.39M39.05M44.09M47.18M148.20M143.56M140.64M
Shareholder's Equity
Total Debt 206.97M98.65M99.28M99.92M
Common Equity 43.50M219.37M178.47M133.58M94.44M68.56M36.83M
Shareholder's Equity 43.50M219.37M178.47M133.58M94.44M68.56M36.83M
Liabilities and Shareholders Equity 307.89M258.42M222.56M180.77M242.64M212.12M177.47M
Retained Earnings -613.73M-14.40M-58.30M-106.13M-149.44M-178.10M-213.40M